Business, energy, technology, markets and global industry news from Business News Today

TERLIVAZ

Pharma & Biotech

Keenova’s TERLIVAZ shows kidney response in transplant-ineligible patients as new CONFIRM analysis emerges

Keenova's TERLIVAZ analysis examines kidney recovery in transplant-ineligible HRS-AKI patients as respiratory safety and survival remain key concerns.

Read More